Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | PALB2 |
| Variant | I944N |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | PALB2 I944N lies within WD repeat 2 of the Palb2 protein (UniProt.org). I944N confers a loss of function to the Palb2 protein as demonstrated by decreased protein stability (PMID: 31757951), reduced Brca2 and Rad51 binding, recruitment to DNA damage sites, and Rad51 foci formation, aberrant cytosolic accumulation (PMID: 31636395), and loss of homology-directed DNA repair activity in cultured cells (PMID: 31636395, PMID: 31757951). |
| Associated Drug Resistance | |
| Category Variants Paths |
PALB2 mutant PALB2 inact mut PALB2 I944N |
| Transcript | NM_024675.4 |
| gDNA | chr16:g.23624012A>T |
| cDNA | c.2831T>A |
| Protein | p.I944N |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_024675 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| NM_001407299.1 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| NM_024675.3 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| XM_017023672.2 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| NM_001407301.1 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| NM_024675.4 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| XM_017023673 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| XM_017023673.2 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| XM_017023672 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| NM_001407300.1 | chr16:g.23624012A>T | c.2831T>A | p.I944N | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| PALB2 I944N | Advanced Solid Tumor | sensitive | Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, cells expressing PALB2 I944N were sensitive to treatment with Lynparza (olaparib) in culture, demonstrating decreased cell survival (PMID: 31636395). | 31636395 |
| PALB2 I944N | Advanced Solid Tumor | sensitive | Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, Lynparza (olaparib) treatment decreased viability of cells expressing PALB2 I944N in culture (PMID: 31757951). | 31757951 |
| PALB2 I944N | Advanced Solid Tumor | sensitive | Cisplatin | Preclinical - Cell culture | Actionable | In a preclinical study, Platinol (cisplatin) decreased survival of cells expressing PALB2 I944N in culture (PMID: 31636395). | 31636395 |